Oppenheimer lowered the firm’s price target on Aspen Aerogels (ASPN) to $13 from $32 and keeps an Outperform rating on the shares. With Aspen working through fluid end-market dynamics and resetting estimates, the firm is derisking its estimates to reflect a more conservative view on U.S. EV sales as the company bridges to a EU EV production ramp in Q4 2025/2026.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels price target lowered to $15 from $20 at Canaccord
- Aspen Aerogels Reports Strong FY 2024 Earnings Growth
- Aspen Aerogels price target lowered to $18 from $21 at Craig-Hallum
- Aspen Aerogels: Strategic Growth Positioning and Financial Resilience Earns Buy Rating
- Cisco jumps after earnings beat, Trump teases reciprocal tariffs: Morning Buzz